Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

CLOROX CO (CLX)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CEST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX CO
09/18 CLOROX : reg; Total 360® System Awarded the Professional Cleaning Industry&rsquo..
09/18 CLOROX : reg; Total 360® System Awarded the Professional Cleaning Industry's Top..
09/13 CLOROX : Declares Regular Quarterly Dividend of 84 Cents Per Share
09/13 CLOROX : Emmy®-Nominated Actress Felicity Huffman Discusses How ‘Being Hum..
09/12 CLOROX : Emmy®-Nominated Actress Felicity Huffman Discusses How 'Being Human Tak..
09/06 CLOROX : to Discuss Progress on 2020 Strategy at Analyst Day on Oct. 5
08/28 INSIDER TRADING ACTIVITY CLOROX COMP : CLX) – SVP Sold 9,223 shares of Sto..
08/28 INSIDER TRADING ACTIVITY CLOROX COMP : CLX) – EVP Sold 9,861 shares of Sto..
08/24 CLOROX CO : Featured Company News - Medline Industries to Buy Clorox's Aplicare ..
08/23 CLOROX CO /DE/ : Regulation FD Disclosure, Financial Statements and Exhibits (fo..
More news
News from SeekingAlpha
12:53p Consumer staples underperform after Dr Pepper warning
07:53a BUYING STOCKS FOR A DIVIDEND GROWTH : Postscript A
09/18 THE IM-CAPITAL STRENGTH 20-STOCK UNI : Update September 2017
09/16 1 Top Stock For 2017 And Beyond
09/13 Clorox declares $0.84 dividend
Financials ($)
Sales 2018 6 149 M
EBIT 2018 1 176 M
Net income 2018 744 M
Debt 2018 1 708 M
Yield 2018 2,50%
P/E ratio 2018 23,89
P/E ratio 2019 22,41
EV / Sales 2018 3,12x
EV / Sales 2019 3,04x
Capitalization 17 472 M
Chart CLOROX CO
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 136 $
Spread / Average Target 0,18%
EPS Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby Chief Operating Officer & Executive VP
Stephen M. Robb Chief Financial Officer & Executive Vice President
Manjit Singh Chief Information Officer & Senior Vice President
Robert W. Matschullat Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO13.46%17 472
RECKITT BENCKISER-0.83%64 395
UNILEVER INDONESIA TBK PT--.--%29 185
CHURCH & DWIGHT CO., INC.14.12%12 398
LION CORP11.17%5 664
KOBAYASHI PHARMACEUTICAL CO LTD30.34%4 763